Johannesburg: A two-dose Pfizer/BioNTech vaccination provides just 33 per cent protection against infection by the omicron variant of the coronavirus, but 70 per cent protection against hospitalisation, according to a large-scale analysis in South Africa released Tuesday. The first large-scale analysis of vaccine effectiveness in the region where the new variant was discovered appears to […]
